vs
KADANT INC（KAI）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
Bio-Techne的季度营收约是KADANT INC的1.1倍（$311.4M vs $271.6M），Bio-Techne净利率更高（16.4% vs 10.2%，领先6.2%），KADANT INC同比增速更快（-0.0% vs -1.5%），过去两年KADANT INC的营收复合增速更高（6.7% vs 1.3%）
Kadant Inc.创立于1991年，最初是Thermo Electron的子公司，部分股权私有、部分公开交易，2001年完成完全分拆并启用现名。公司服务于造纸、废纸回收、木材加工、物料搬运等多个加工领域，是业务覆盖亚洲、欧洲、北美、南美的跨国企业。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
KAI vs TECH — 直观对比
营收规模更大
TECH
是对方的1.1倍
$271.6M
营收增速更快
KAI
高出1.5%
-1.5%
净利率更高
TECH
高出6.2%
10.2%
两年增速更快
KAI
近两年复合增速
1.3%
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $271.6M | $311.4M |
| 净利润 | $27.7M | $51.0M |
| 毛利率 | 45.2% | 66.9% |
| 营业利润率 | 15.7% | 24.2% |
| 净利率 | 10.2% | 16.4% |
| 营收同比 | -0.0% | -1.5% |
| 净利润同比 | -12.2% | 126.0% |
| 每股收益（稀释后） | $2.35 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KAITECH
| Q1 26 | — | $311.4M | ||
| Q4 25 | — | $295.9M | ||
| Q3 25 | $271.6M | — | ||
| Q2 25 | $255.3M | $317.0M | ||
| Q1 25 | $239.2M | $316.2M | ||
| Q4 24 | $258.0M | $297.0M | ||
| Q3 24 | $271.6M | $289.5M | ||
| Q2 24 | $274.8M | $306.1M |
净利润KAITECH
| Q1 26 | — | $51.0M | ||
| Q4 25 | — | $38.0M | ||
| Q3 25 | $27.7M | — | ||
| Q2 25 | $26.2M | $-17.7M | ||
| Q1 25 | $24.1M | $22.6M | ||
| Q4 24 | $24.0M | $34.9M | ||
| Q3 24 | $31.6M | $33.6M | ||
| Q2 24 | $31.3M | $40.6M |
毛利率KAITECH
| Q1 26 | — | 66.9% | ||
| Q4 25 | — | 64.6% | ||
| Q3 25 | 45.2% | — | ||
| Q2 25 | 45.9% | 62.7% | ||
| Q1 25 | 46.1% | 67.9% | ||
| Q4 24 | 43.4% | 65.3% | ||
| Q3 24 | 44.7% | 63.2% | ||
| Q2 24 | 44.4% | 66.4% |
营业利润率KAITECH
| Q1 26 | — | 24.2% | ||
| Q4 25 | — | 18.4% | ||
| Q3 25 | 15.7% | — | ||
| Q2 25 | 15.4% | -7.5% | ||
| Q1 25 | 14.9% | 12.2% | ||
| Q4 24 | 14.3% | 16.0% | ||
| Q3 24 | 18.0% | 13.8% | ||
| Q2 24 | 17.6% | 15.0% |
净利率KAITECH
| Q1 26 | — | 16.4% | ||
| Q4 25 | — | 12.8% | ||
| Q3 25 | 10.2% | — | ||
| Q2 25 | 10.2% | -5.6% | ||
| Q1 25 | 10.1% | 7.1% | ||
| Q4 24 | 9.3% | 11.7% | ||
| Q3 24 | 11.6% | 11.6% | ||
| Q2 24 | 11.4% | 13.3% |
每股收益（稀释后）KAITECH
| Q1 26 | — | $0.32 | ||
| Q4 25 | — | $0.24 | ||
| Q3 25 | $2.35 | — | ||
| Q2 25 | $2.22 | $-0.11 | ||
| Q1 25 | $2.04 | $0.14 | ||
| Q4 24 | $2.04 | $0.22 | ||
| Q3 24 | $2.68 | $0.21 | ||
| Q2 24 | $2.66 | $0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $124.5M | $209.8M |
| 总债务越低越好 | $254.6M | — |
| 股东权益账面价值 | $949.8M | $2.1B |
| 总资产 | $1.5B | $2.6B |
| 负债/权益比越低杠杆越低 | 0.27× | — |
8季度趋势，按日历期对齐
现金及短期投资KAITECH
| Q1 26 | — | $209.8M | ||
| Q4 25 | — | $172.9M | ||
| Q3 25 | $124.5M | — | ||
| Q2 25 | $95.3M | $162.2M | ||
| Q1 25 | $91.7M | $140.7M | ||
| Q4 24 | $94.7M | $177.5M | ||
| Q3 24 | $88.4M | $187.5M | ||
| Q2 24 | $73.8M | $152.9M |
总债务KAITECH
| Q1 26 | — | — | ||
| Q4 25 | — | $260.0M | ||
| Q3 25 | $254.6M | — | ||
| Q2 25 | $245.7M | $346.0M | ||
| Q1 25 | $273.5M | $330.0M | ||
| Q4 24 | $285.2M | $300.0M | ||
| Q3 24 | $323.2M | $300.0M | ||
| Q2 24 | $342.0M | $319.0M |
股东权益KAITECH
| Q1 26 | — | $2.1B | ||
| Q4 25 | — | $2.0B | ||
| Q3 25 | $949.8M | — | ||
| Q2 25 | $926.0M | $1.9B | ||
| Q1 25 | $876.0M | $2.0B | ||
| Q4 24 | $847.1M | $2.1B | ||
| Q3 24 | $851.7M | $2.1B | ||
| Q2 24 | $807.7M | $2.1B |
总资产KAITECH
| Q1 26 | — | $2.6B | ||
| Q4 25 | — | $2.5B | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | $2.6B | ||
| Q1 25 | $1.4B | $2.6B | ||
| Q4 24 | $1.4B | $2.7B | ||
| Q3 24 | $1.5B | $2.7B | ||
| Q2 24 | $1.5B | $2.7B |
负债/权益比KAITECH
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | 0.27× | — | ||
| Q2 25 | 0.27× | 0.18× | ||
| Q1 25 | 0.31× | 0.16× | ||
| Q4 24 | 0.34× | 0.14× | ||
| Q3 24 | 0.38× | 0.14× | ||
| Q2 24 | 0.42× | 0.15× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $47.3M | — |
| 自由现金流经营现金流 - 资本支出 | $44.1M | — |
| 自由现金流率自由现金流/营收 | 16.2% | — |
| 资本支出强度资本支出/营收 | 1.2% | — |
| 现金转化率经营现金流/净利润 | 1.70× | — |
| 过去12个月自由现金流最近4个季度 | $145.9M | — |
8季度趋势，按日历期对齐
经营现金流KAITECH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $47.3M | — | ||
| Q2 25 | $40.5M | $98.2M | ||
| Q1 25 | $22.8M | $41.1M | ||
| Q4 24 | $51.9M | $84.3M | ||
| Q3 24 | $52.5M | $63.9M | ||
| Q2 24 | $28.1M | $75.5M |
自由现金流KAITECH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $44.1M | — | ||
| Q2 25 | $36.5M | $93.3M | ||
| Q1 25 | $19.0M | $31.0M | ||
| Q4 24 | $46.3M | $77.5M | ||
| Q3 24 | $48.3M | $54.7M | ||
| Q2 24 | $23.1M | $57.5M |
自由现金流率KAITECH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 16.2% | — | ||
| Q2 25 | 14.3% | 29.4% | ||
| Q1 25 | 7.9% | 9.8% | ||
| Q4 24 | 17.9% | 26.1% | ||
| Q3 24 | 17.8% | 18.9% | ||
| Q2 24 | 8.4% | 18.8% |
资本支出强度KAITECH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 1.6% | 1.5% | ||
| Q1 25 | 1.6% | 3.2% | ||
| Q4 24 | 2.2% | 2.3% | ||
| Q3 24 | 1.5% | 3.2% | ||
| Q2 24 | 1.8% | 5.9% |
现金转化率KAITECH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.55× | — | ||
| Q1 25 | 0.95× | 1.82× | ||
| Q4 24 | 2.16× | 2.42× | ||
| Q3 24 | 1.66× | 1.90× | ||
| Q2 24 | 0.90× | 1.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KAI
| Flow Control | $94.8M | 35% |
| Capital | $83.2M | 31% |
| Material Handling Systems | $70.3M | 26% |
| Transferred Over Time | $17.1M | 6% |
| Other | $6.1M | 2% |
TECH
| Protein Sciences segment revenue | $226.2M | 73% |
| Diagnostics and Spatial Biology segment revenue | $85.6M | 27% |
| Other revenue (1) | $5.4M | 2% |
